c) Toxicity (except for alopecia) related to prio r anti-cancer therapy and/or surgery, unless the toxicity is either resolved, returned to baseline or Grade 1, or deemed irreversible. i) Any active neuropathy Grade > 2 (NCI CTCAE v4.0327). d) Participants with the following: i) Active, known, or suspected autoimmune disease. (1).Participants with well-controlled as thma and/or mild allergic rhinitis (seasonal allergies) are eligible. (2).Participants with the following disease conditions are also eligible: a. Vitiligo.